RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS

Clinical trials for RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS trials appear

Sign up with your email to follow new studies for RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a blood vessel drug ease Raynaud's in scleroderma?

Symptom relief Completed

This Phase 2 trial tested whether selexipag, a drug that opens blood vessels, can reduce the number of Raynaud's attacks in adults with systemic sclerosis. 74 participants took either selexipag or a placebo twice daily. The main goal was to see if the drug lowered weekly attack f…

Matched conditions: RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS

Phase: PHASE2 • Sponsor: Actelion • Aim: Symptom relief

Last updated Jun 27, 2026 13:01 UTC

RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS

Get alerted when new RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS trials appear

Can a blood vessel drug ease Raynaud's in scleroderma?